Position in LLY
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$220,337,708
+$71,897,868 QoQ
Shares Held
183,702
+13.8% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.73%
of 13F equity value
Holder Rank
#250
of 4,605 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 6%
Shared 0%
None 94%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Derivatives in LLY
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$2,039,031
PutShares
1,700
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WEALTH ENHANCEMENT ADVISORY SERVICES, LLC holds $1,542,735,587 across 15 Drug Manufacturers - General names. LLY ranks #2 (14.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
1,833,813 | $465,733,487 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
183,702 | $220,337,708 | |
| 3 | MRK |
Merck & Co., Inc.
|
1,625,531 | $208,880,733 | |
| 4 | AMGN |
Amgen Inc
|
464,220 | $168,103,346 | |
| 5 | ABBV |
AbbVie Inc.
|
576,543 | $145,081,280 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
1,764,695 | $101,681,725 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
603,836 | $76,288,640 | |
| 8 | PFE |
Pfizer Inc
|
3,158,575 | $76,058,486 |
All Filings in LLY
Export CSV
32 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $220,337,708 | 183,702 | Shares | Sole | 2026-07-15 | |
| 2026-06-30 | $2,039,031 | 1,700 | Put | Sole | 2026-07-15 | |
| 2026-03-31 | $148,439,840 | 161,388 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $229,966,495 | 213,986 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $154,254,947 | 202,169 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $146,497,852 | 187,931 | Shares | Sole | 2025-07-10 | |
| 2025-03-31 | $125,426,822 | 151,865 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $106,668,784 | 138,172 | Shares | Sole | 2025-03-17 | |
| 2024-09-30 | $148,588,084 | 167,718 | Shares | Sole | 2024-10-24 | |
| 2024-09-30 | $72,559 | 1,700 | Put | Sole | 2024-10-24 | |
| 2024-06-30 | $142,192,645 | 157,053 | Shares | Sole | 2024-07-16 | |
| 2024-06-30 | $1,043 | 700 | Put | Sole | 2024-07-16 | |
| 2024-03-31 | $104,596,722 | 134,450 | Shares | Sole | 2024-04-15 | |
| 2024-03-31 | $12,970 | 1,700 | Put | Sole | 2024-04-15 | |
| 2024-03-31 | $54,000 | 500 | Call | Sole | 2024-04-15 | |
| 2023-12-31 | $66,887 | 1,700 | Put | Sole | 2024-01-30 | |
| 2023-12-31 | $1,165,840 | 2,000 | Call | Sole | 2024-01-30 | |
| 2023-12-31 | $72,078,058 | 123,650 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $63,972,720 | 119,101 | Shares | Sole | 2023-11-13 | |
| 2023-09-30 | $190,300 | 2,000 | Call | Sole | 2023-11-13 | |
| 2023-06-30 | $18,344,152 | 39,115 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $14,775,988 | 43,026 | Shares | Sole | 2023-04-25 | |
| 2022-12-31 | $12,189,788 | 33,320 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $2,542,501 | 7,863 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $5,386,757 | 16,614 | Shares | Sole | 2022-07-18 | |
| 2021-09-30 | $5,256,387 | 22,750 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $8,305,181 | 36,185 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $9,641,967 | 51,611 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $8,500,756 | 50,348 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $4,693,418 | 31,708 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,491,739 | 9,086 | Shares | Sole | 2020-10-13 | |
| 2020-03-31 | $5,039,697 | 36,330 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||